Irish solution for Pegasys shortage


TGA approves Irish-labelled stock of chronic hepatitis treatment, Pegasys, as shortage hits Australia  Fresh supplies of overseas-labelled Pegasys (peginterferon alfa 2a) are expected to arrive next month (July), the medication’s sponsor, Echo Therapeutics says.   Echo notified the Therapeutic Goods Administration (TGA) last month that as of 19 May 2025, stock of Pegasys injection 180

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next Pharmacists lack vaping support